Homepage / Programme Live /

GLP-1 receptor agonist liraglutide in Wolfram syndrome type 1: effects on endogenous insulin secretion - (P-162)

Talk details

Poster Corner 8 THURSDAY: Outcomes and Care Models; Childhood Obesity and Type 2 Diabetes; Chronic Complications; Monogenic and other forms of Diabetes
Monogenic and other forms of Diabetes
GLP-1 receptor agonist liraglutide in Wolfram syndrome type 1: effects on endogenous insulin secretion (P-162)
M. MATARAZZO
06/11/2025 15:15 - 16:15 CEST